Bovie Medical Corporation Files 510(K) Submission with the FDA for a New Indication to Market and Sell J-PLASMA/RENUVION for use in Dermal Resurfacing ProceduresBy ApyxMedical|2025-12-12T19:49:44+00:00December 21, 2018|
Bovie Medical Corporation Announces Appointment of Tara H. Semb as Chied Financial OfficerBy ApyxMedical|2025-12-12T19:50:07+00:00December 17, 2018|
BOVIE MEDICAL CORPORATION ANNOUNCES CORPORATE NAME CHANGE TO APYX MEDICAL CORPORATION AND PLANS TO TRANSITION COMMON STOCK LISTING TO NASDAQ GLOBAL SELECT MARKETBy ApyxMedical|2026-01-14T22:13:03+00:00December 12, 2018|
